AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL...
AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strateg...
AACR 2009: Combined Inhibition of Histone Deacetylase and mtor: A Novel Therapeu...
AACR 2009: Molecular profiling of tumours to find potential targets and treatmen...
Gangning Liang, MD, Ph.D., associate professor of research, department of urolog...
ecancertv |
(0) (0 Votes)
|
Views: (819) Date: (07-04-10) Time: (00:03:40) |
Description: AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers. Daniel Von Hoff, MD, senior investigator/physician-in-chief, tgen; chief scientific officer, Scottsdale Healthcare and US Oncology Research, speaking at AACR 2009, Denver: A Pilot Study Utilizing Molecular Profiling of Tumours to Find Potential Targets and Select Treatments for Their Refractory Cancers